Danka Pavliakova - Montebello NY, US Eric Hryhorenko - Hilton NY, US Stephen Hildreth - Clarks Summit PA, US
Assignee:
ELAN PHARMACEUTICALS, INC. - South San Francisco CA
International Classification:
G01N 33/537 G01N 33/53 G01N 33/543
US Classification:
435007920
Abstract:
The invention provides methods for assessing immunoglobulins directed to neurodegenerative disease-associated antigens. Methods of the instant invention involve specific, sensitive and precise identification of Ig classes of antibodies present in a test sample that are capable of binding an immobilized neurodegenerative disease-associated antigen. The enhanced assessment of antibodies directed to specific neurodegenerative disease-associated antigens that is enabled by the invention improves both monitoring of neurodegenerative disease treatment and prediction of neurodegenerative disease progression.
- Beerse, BE Rhys Salter - Doylestown PA, US Thomas R. DeCory - Pittsford NY, US Eric Hryhorenko - Hilton NY, US Bart Remmerie - Gent, BE Banumathi Sankaran - Lexington MA, US
The invention relates to compounds of Formula I, wherein R, R, and Rare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
- Beerse, BE Rhys Salter - Doylestown PA, US Thomas R. Decory - Pittsford NY, US Eric Hryhorenko - Hilton NY, US Bart M. Remmerie - Gent, BE Banumathi Sankaran - Pittsford NY, US
The invention relates to compounds of Formula I, wherein R, R, and Rare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
- Raritan NJ, US - Beerse, BE Rhys Salter - Doylestown PA, US Eric Hryhorenko - Hilton NY, US Thomas R. DeCory - Pittsford NY, US Bart Remmerie - Gent, BE Banumathi Sankaran - Pittsford NY, US
The invention relates to compounds of Formula I, wherein R, R, and Rare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from quetiapine. The invention also relates to conjugates of a quetiapine hapten and a protein.
- Raritan NJ, US - Beerse, BE Rhys SALTER - Doylestown PA, US Eric HRYHORENKO - Hilton NY, US Thomas R. DeCORY - Pittsford NY, US Bart REMMERIE - Gent, BE Banumathi SANKARAN - Pittsford NY, US
The invention relates to compounds of Formula I, wherein R, R, and Rare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from olanzipine. The invention also relates to conjugates of an olanzipine hapten and a protein.
The invention relates to compounds of Formula I, wherein L, L, and Lare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from paliperidone. The invention also relates to conjugates of a paliperidone hapten and a protein.
- Raritan NJ, US - Beerse, BE Thomas R. DeCORY - Pittsford NY, US Eric HRYHORENKO - Hilton NY, US Bart REMMERIE - Gent, BE Banumathi SANKARAN - Pittsford NY, US
The invention relates to compounds of Formula I, wherein R, R, and Rare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from aripiprazole. The invention also relates to conjugates of an aripiprazole hapten and a protein.
The invention relates to compounds of Formula I, wherein Rand Rare defined in the specification, useful for the synthesis of novel conjugates and immunogens derived from risperidone and paliperidone. The invention also relates to conjugates of a risperidone or paliperidone hapten and a protein.